Xencor

Develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.

HQ location

Monrovia, United States

Website

Launch date

1997

Employees

Market cap

Enterprise value

$196m

Share price

$8.05 XNCR

Jobs

View job openings

Recent deals

Zenas BioPharma

https://twitter.com/xencor https://www.linkedin.com/company/xencor/

Authorizing premium user...